Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs

The effectiveness of combined drugs, consisting of chondroitin and glucosamine (GA) in the treatment of osteoarthritis (OA) is discussed. Due to their high safety and pleiotropic effects, these drugs can be used in patients with OA (primarily with metabolic and inflammatory phenotypes) and comorbid...

Full description

Bibliographic Details
Main Author:	E. V. Zonova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2021-04-01
Series:	Современная ревматология
Subjects:	osteoarthritis treatment symptomatic slow-acting drugs in osteoarthritis treatment glucosamine chondroitin sulfate
Online Access:	https://mrj.ima-press.net/mrj/article/view/1133

id	doaj-58e424e27a7544fcb8dae3caf3104e25
record_format	Article
spelling	doaj-58e424e27a7544fcb8dae3caf3104e252021-07-29T09:00:14ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2021-04-0115212613110.14412/1996-7012-2021-2-126-1312354Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugsE. V. Zonova0Novosibirsk state medical universityThe effectiveness of combined drugs, consisting of chondroitin and glucosamine (GA) in the treatment of osteoarthritis (OA) is discussed. Due to their high safety and pleiotropic effects, these drugs can be used in patients with OA (primarily with metabolic and inflammatory phenotypes) and comorbid diseases. The effect of oral chondroitin and GA on the intestinal microbiota is described: regulation of the composition, metabolic and immunological activity of intestinal microbiota. The relationship between the regular administration of chondroitin and GA and decrease in overall mortality and mortality from cardiovascular diseases, as well as the decrease of malignancy development risk is marked.https://mrj.ima-press.net/mrj/article/view/1133osteoarthritistreatmentsymptomatic slow-acting drugs in osteoarthritis treatmentglucosaminechondroitin sulfate
collection	DOAJ
language	Russian
format	Article
sources	DOAJ
author	E. V. Zonova
spellingShingle	E. V. Zonova Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs Современная ревматология osteoarthritis treatment symptomatic slow-acting drugs in osteoarthritis treatment glucosamine chondroitin sulfate
author_facet	E. V. Zonova
author_sort	E. V. Zonova
title	Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
title_short	Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
title_full	Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
title_fullStr	Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
title_full_unstemmed	Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
title_sort	advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
publisher	IMA-PRESS LLC
series	Современная ревматология
issn	1996-7012 2310-158X
publishDate	2021-04-01
description	The effectiveness of combined drugs, consisting of chondroitin and glucosamine (GA) in the treatment of osteoarthritis (OA) is discussed. Due to their high safety and pleiotropic effects, these drugs can be used in patients with OA (primarily with metabolic and inflammatory phenotypes) and comorbid diseases. The effect of oral chondroitin and GA on the intestinal microbiota is described: regulation of the composition, metabolic and immunological activity of intestinal microbiota. The relationship between the regular administration of chondroitin and GA and decrease in overall mortality and mortality from cardiovascular diseases, as well as the decrease of malignancy development risk is marked.
topic	osteoarthritis treatment symptomatic slow-acting drugs in osteoarthritis treatment glucosamine chondroitin sulfate
url	https://mrj.ima-press.net/mrj/article/view/1133
work_keys_str_mv	AT evzonova advantagesofosteoarthritiscombinedtreatmentwithsymptomaticslowactingdrugs
_version_	1721250153343483904

Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs

Similar Items